ArticleJournal of gastrointestinal oncology2022

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using

Baruch Brenner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.